Phathom Pharmaceuticals (PHAT) PT Raised to $12 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Phathom Pharmaceuticals Inc. (PHAT) spreader active in August 10 and November 10 calls
August 8, 2024 2:53 PM EDTPhathom Pharmaceuticals Inc. (NASDAQ: PHAT) 30-day option implied volatility is at 82; compared to its 52-week range of 55 to 180 with a focus on August 10 and November 10 call spread.
... MorePhathom Pharmaceuticals, Inc. (PHAT) Tops Q2 EPS by 7c
August 8, 2024 8:05 AM EDTPhathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q2 EPS of ($1.25), $0.07 better than the analyst estimate of ($1.32). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $5.68 million.
For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.
... More


